85 related articles for article (PubMed ID: 3492131)
1. T-lymphocyte subsets and their cytotoxic capacity in patients with type I and type II diabetes mellitus.
Horváth M; Varsányi M; Jovanovich N; Rózsás Z; Balázsi I
Allergol Immunopathol (Madr); 1986; 14(5):399-405. PubMed ID: 3492131
[TBL] [Abstract][Full Text] [Related]
2. Similar alterations of lymphocyte subpopulations in type I and type II diabetes.
Spooren PF; Vermes I; Soons JW
Neth J Med; 1993 Jun; 42(5-6):163-7. PubMed ID: 8377873
[TBL] [Abstract][Full Text] [Related]
3. Immune reactions in patients with type I and with type II diabetes mellitus.
Horváth M; Varsányi M; Jovanovich N; Rózsás Z; Balázsi I
Exp Clin Endocrinol; 1987 Aug; 89(3):354-62. PubMed ID: 3499333
[TBL] [Abstract][Full Text] [Related]
4. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
[TBL] [Abstract][Full Text] [Related]
5. Analysis of recently activated, memory and naive lymphocyte T subsets in the peripheral blood of patients with Graves' disease and insulin-dependent diabetes mellitus.
Kretowski A; Myśliwiec J; Turowski D; Wysocka J; Kinalska I
Rocz Akad Med Bialymst; 1999; 44():226-34. PubMed ID: 10697437
[TBL] [Abstract][Full Text] [Related]
6. [Immunological aspects of wound healing in patients with diabetes mellitus].
Kim AIu; Morozov IuI; Kirdeĭ EG
Klin Med (Mosk); 1994; 72(6):48-50. PubMed ID: 7898011
[TBL] [Abstract][Full Text] [Related]
7. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
[TBL] [Abstract][Full Text] [Related]
8. Characterization of immunoregulatory T lymphocytes in insulin-dependent diabetic children by means of monoclonal antibodies.
Mascart-Lemone F; Delespesse G; Dorchy H; Lemiere B; Servais G
Clin Exp Immunol; 1982 Feb; 47(2):296-300. PubMed ID: 6210472
[TBL] [Abstract][Full Text] [Related]
9. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.
Sobel DO; Creswell K
Autoimmunity; 2006 Jun; 39(4):323-32. PubMed ID: 16891221
[TBL] [Abstract][Full Text] [Related]
10. In vitro effect of insulin on peripheral T-lymphocyte E-rosette function from normal and diabetic subjects.
Cattaneo R; Saibene V; Margonato A; Pozza G
Boll Ist Sieroter Milan; 1977 Mar; 56(2):139-43. PubMed ID: 326272
[TBL] [Abstract][Full Text] [Related]
11. Metabolic state does not influence lymphocyte subsets in type 1 diabetic patients.
Buschard K; Birch K; Madsbad S; Röpke C
Diabetes Res; 1988 Sep; 9(1):15-8. PubMed ID: 3071440
[TBL] [Abstract][Full Text] [Related]
12. [The functional activity and count of the natural killer cells in patients with recently diagnosed diabetes mellitus types I and II].
Salozhin KV; Sura VV; Nasonov EL; Korneeva MN; Smirnova OI
Ter Arkh; 1989; 61(10):104-6. PubMed ID: 2609254
[TBL] [Abstract][Full Text] [Related]
13. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
14. Non-specific cellular immunity in type I and type II diabetes.
Fövenyi J; Tótpál K; Thaisz E; Garam T
Exp Clin Endocrinol; 1984 Apr; 83(2):203-6. PubMed ID: 6539221
[TBL] [Abstract][Full Text] [Related]
15. Analysis of T-lymphocyte subpopulations in juvenile-onset diabetics.
Müller R; Kolb H; Kuschak D; Jörgens V; Gries FA
Clin Exp Immunol; 1980 Jan; 39(1):130-5. PubMed ID: 6966986
[TBL] [Abstract][Full Text] [Related]
16. Alterations of peripheral T-lymphocyte subpopulations in patients with insulin-dependent (type 1) diabetes mellitus.
Buschard K; Röpke C; Madsbad S; Mehlsen J; Sørensen TB; Rygaard J
J Clin Lab Immunol; 1983 Mar; 10(3):127-31. PubMed ID: 6221108
[TBL] [Abstract][Full Text] [Related]
17. In vivo determination of cell mediated immune response in diabetic patients using a multiple intradermal antigen dispenser.
Pozzilli P; Pagani S; Arduini P; Visalli N; Cioccia GP; Negri M; Andreani D
Diabetes Res; 1987 Sep; 6(1):5-8. PubMed ID: 3500820
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte populations and responses to mitogens in infants of diabetic mothers.
El Mohandes A; Touraine JL; Touraine F; Shukry AS; Salle B
J Clin Lab Immunol; 1982 May; 8(1):25-9. PubMed ID: 6212685
[TBL] [Abstract][Full Text] [Related]
19. [Heterogeneity of diabetes mellitus].
Asfandiiarova NS; Kolcheva NG; Shatrova IV
Ter Arkh; 1999; 71(12):49-52. PubMed ID: 10647203
[TBL] [Abstract][Full Text] [Related]
20. Autologous mixed lymphocyte reaction in man. VI. Deficiency of autologous mixed lymphocyte reaction in type I (insulin-dependent) diabetes mellitus.
Gupta S; Fikrig S; Orti E
J Clin Lab Immunol; 1983 Jun; 11(2):59-62. PubMed ID: 6224017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
